-
Mashup Score: 1FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma - PubMed - 7 day(s) ago
Early FDG PET/CT can identify metabolic changes in melanoma metastases that are potentially predictive of response to pembrolizumab and significantly correlated with PFS.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 102
A phase 2 trial led by a NewYork-Presbyterian/Weill Cornell Medicine oncologist reveals the efficacy of neoadjuvant botensilimab plus balstilimab in patients with colorectal cancer.
Source: www.nyp.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 44The Promise of Liquid Biopsies | Cancer Today - 20 day(s) ago
Blood tests that detect traces of cancer cells and tumor DNA help find residual disease after treatment is completed.
Source: www.cancertodaymag.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 27
Listen to this episode from The Late Night Oncology Show on Spotify. [Episódio em Inglês] Para fechar o mês de conscientização dos tumores colorretais, recebemos Dr. Pashtoon Kasi, oncologista clínico com foco em tumores gastrointestinais, professor na Weill Cornell Medicine e autor do estudo BESPOKE CRC, para discutir aspectos relacionados a biópsia líquida em câncer colorretal, incluindo a importância na detecção precoce, determinação de tratamento adjuvante e monitoramento do tratamento no cenário metastático.
Source: open.spotify.comCategories: General Medicine News, Hem/OncsTweet-
Was a delight to be on the @LateNightOnc🎙️🇧🇷 in the company of some wonderful physicians & scientists discussing #ctDNA🧬🩸. 👇🏾Episode available on Spotify. 💡More now than ever it is important to understand the limitations & best use case/scenarios. https://t.co/vMpl6O6o1m https://t.co/iJi6kNzSAY https://t.co/wZSBT6Dvvn
-
-
Mashup Score: 88Ongoing Research Shows Promising Results for Neoadjuvant Treatment for Colorectal Cancer - Advances in Gastroenterology & Oncology | NewYork-Presbyterian - 1 month(s) ago
A phase 2 trial led by a NewYork-Presbyterian/Weill Cornell Medicine oncologist reveals the efficacy of neoadjuvant botensilimab plus balstilimab in patients with colorectal cancer.
Source: www.nyp.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 140Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer - 1 month(s) ago
Oncogene – Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 12Blood-based colorectal cancer screening in an integrated health system: a randomised trial of patient adherence - 1 month(s) ago
Objective We evaluated whether people who had not completed a faecal immunochemical test (FIT) for colorectal cancer (CRC) screening would complete a blood-based testing option if offered one during health encounters. Blood-based screening tests for CRC could add to the total number of people screened for CRC by providing another testing alternative. Design Study participants were patients aged 45–75 years at a large, integrated health system who were offered but did not complete an FIT in the prior 3–9 months and were scheduled for a clinical encounter. Individuals were randomised (1:1) to be offered a commercially available CRC blood test (Shield, Guardant Health) versus usual care. We compared 3-month CRC screening proportions in the two groups. Results We randomised 2026 patients; 2004 remained eligible following postrandomisation exclusions (1003 to usual care and 1001 to blood draw offer; mean age: 60, 62% female, 80% non-Hispanic white). Of the 1001 allocated to the blood test g
Source: gut.bmj.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 49Attacking Colorectal Cancer From the Roots Up - 2 month(s) ago
Giving two immunotherapy drugs before surgery to remove colorectal cancer shows highly promising results
Source: www.scientificamerican.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 208th Liquid Biopsy for Precision Oncology Summit - 2 month(s) ago
Reimagine Cancer Detection, Diagnosis & Patient Management through Harnessing the Potential of Liquid Biopsies
Source: lbx-summit.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer - 2 month(s) ago
Oncogene – Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
RT @BReinfeld: @pashtoonkasi @RareCyte https://t.co/wlXslkmY7S I think there is growing evidence that it is on the order of weeks in at le…